Thoracoscopic Right Upper Mediastinal Dissection for Left Lung Cancer

被引：0
作者：
Kawahara K. [1 ,2 ]
Shiraishi T. [1 ]
Iwasaki A. [1 ]
Yoshinaga Y. [1 ]
Yamamoto S. [1 ]
Yoneda S. [1 ]
Shirakusa T. [1 ]
机构：
[1] Second Department of Surgery, Fukuoka Univ. School of Medicine, Fukuoka
[2] Second Department of Surgery, Fukuoka Univ. School of Medicine, Fukuoka 814-0180
来源：
The Japanese Journal of Thoracic and Cardiovascular Surgery | 2002年 / 50卷 / 10期
关键词：
Lung cancer; Lymph node dissection; Micrometastasis; Thoracoscopic surgery;
D O I：
10.1007/BF02913175
中图分类号：
学科分类号：
摘要：
Objective: In left lung cancer, left and right mediastinum lymphatic spread occur equally frequently. We evaluated the safety and effectiveness of thoracoscopic right upper mediastinal dissection, implemented prior to left lung resection for left lung cancer. Methods: Between January 1999 and May 2000, 17 patients with left lung cancer underwent thoracoscopic right upper mediastinal dissection prior to resection of the left lung and left mediastinal dissection for left lung cancer. These patients had either enlarged left hilar or bilateral mediastinal nodes, or either a tumor at least 3 cm in diameter or tumor extension to the hilum, mediastinum, or chest wall. Tumor and lymph nodes were examined with hematoxylin and eosin and immunohistochemical staining of cytokeratin for micrometastasis. Results: In 3 patients (17.6%), metastasis occurred in right paratracheal nodes. The 30-day mortality was 0% and morbidity 35.3% (6/17). Postoperative complications occurred in 3 of 4 patients (75%) undergoing induction chemotherapy, but none were lethal. Conclusion: Thoracoscopic right upper mediastinal dissection is safe and feasible in treating advanced left lung cancer.
引用
收藏
页码：418 / 423
页数：5
相关论文
共 7 条
  • [1] Nohl-Oser H.C., Lymphatics of the lung, General Thoracic Surgery, pp. 68-75, (1989)
  • [2] Caplan I., Anatomical review of the lymph nodes of the human mediastinum, Surg Radiol Anat, 12, pp. 9-18, (1990)
  • [3] Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Kanus W.A., Et al., American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Crit Care Med, 20, pp. 864-874, (1992)
  • [4] Chen Z.K., Perez S., Holmes E.C., Wang H.J., Caulson W.F., Wen D.R., Et al., Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small cell lung carcinoma, J Natl Cancer Inst, 85, pp. 493-498, (1993)
  • [5] Dobashi K., Sugio K., Osaki T., Oka T., Yasumoto K., Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance, J Thorac Cardiovasc Surg, 114, pp. 339-346, (1997)
  • [6] Passilick B., Izbiki J.R., Kubuschok B., Thetter O., Pantel K., Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis, Ann Thorac Surg, 61, pp. 177-183, (1996)
  • [7] Hata E., Miyamoto H., Kohiyama R., Tanaka M., Sakao Y., Harada R., Resection of N2/N3 disease, Lung Cancer Frontiers in Science and Treatment, pp. 431-448, (1994)
1